CD4 and neoplasm: CAELYX® alone decreased the number of CD4+ T cells inside the tumor parenchyma (Fig. 5d), while CAELYX® and LTX-315 alone induced a significant increase in tumor-infiltrating CD8+ T cells (Fig. 5e).